EWM
ARKG icon

Elite Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Elite Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-43,578
Closed -$1.21M – 44
2023
Q3 		$1.21M Buy
43,578
+15,640
+56% +$511K 0.09% 30
2023
Q2 		$952K Buy
27,938
+12,757
+84% +$401K 0.07% 32
2023
Q1 		$456K Sell
15,181
-259
-2% -$8.03K 0.03% 39
2022
Q4 		$436K Sell
15,440
-53
-0.3% -$1.68K 0.04% 40
2022
Q3 		$509K Sell
15,493
-581
-4% -$21.3K 0.04% 36
2022
Q2 		$506K Buy
16,074
+345
+2% +$12.1K 0.08% 35
2022
Q1 		$722K Sell
15,729
-724
-4% -$34.5K 0.12% 32
2021
Q4 		$1.01M Sell
16,453
-701
-4% -$48.5K 0.14% 30
2021
Q3 		$1.28M Buy
17,154
+685
+4% +$57.5K 0.24% 31
2021
Q2 		$1.52K Buy
16,469
+118
+0.7% +$10K 0.14% 26
2021
Q1 		$1.45K Buy
16,351
+253
+2% +$25.1K 0.19% 26
2020
Q4 		$1.5M Buy
+16,098
New +$1.28M 0.19% 24

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MM
Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Elite Wealth Management's ARKG Position: Q4 2023 in Review

Elite Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 43,578 shares — an estimated $1.21M sold.

Elite Wealth Management first reported a position in ARKG in Q4 2020 and held it in 12 quarters. The position peaked at $1.5M in Q4 2020. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Elite Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Elite Wealth Management sold 43,578 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $1.21M.
  • Elite Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 12 quarters.
  • Elite Wealth Management's ARK Genomic Revolution ETF position peaked at $1.5M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Elite Wealth Management's 13F filing for Q4 2023, filed 30 Jan 2024.